Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Management of Adults and Adolescents with Alopecia Areata
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Sickle Cell Disease Transition in Care
Release Date:
Partner: National Alliance of Sickle Cell Centers
Review Process: Expert Review Panel
Quality Improvement Rare Disease USA
Title
Grant Type
Focus Area
Country
Application Due Date
Enzalutamide in the Treatment of Prostate Cancer
Release Date:
Partner: National Comprehensive Cancer Network, Astellas
Review Process: Expert Review Panel
Research Oncology USA
Education of Healthcare Professionals to Provide Appropriate Medical Care for Patients with Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology Japan
Addressing Primary Immunodeficiencies within Minority/Underserved Populations
Release Date:
Review Process: Pfizer Internal
Education Hospital USA
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research – U.S.
Release Date:
Review Process: Pfizer Internal
Research Rare Disease USA
Patient and Caregiver Awareness of Drug Resistant Infections (United States and Europe)
Release Date:
Review Process: Pfizer Internal
Education Hospital All
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Nurse Navigator Competitive Grant Program
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease USA
Establishment of Hospital-Clinic Collaboration Model for Undiagnosed Rheumatic Diseases
Release Date:
Partner: The Japan College of Rheumatology
Review Process: Expert Review Panel
Quality Improvement Inflammation & Immunology Japan
Establishment of Support System for Healthy Life Extension of Patients with CV disease
Release Date:
Review Process: Expert Review Panel
Quality Improvement Internal Medicine Japan
A Quality Improvement Grant Request for Proposals Addressing Social Health Needs in Chronic and Preventative Disease
Release Date:
Partner: IHI
Review Process: Expert Review Panel
Quality Improvement Internal Medicine USA
Racial and Ethnic Disparities in the Menopause Experience
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine USA
Immunotherapy in Urothelial Carcinoma
Release Date:
Partner: Merck KGaA Darmstadt, Germany and EMD Serono
Review Process: Pfizer Internal
Education Oncology All
Managment of Metabolic Risks that Drive Liver Diseases and Increase Cardiovascular Risk in NASH
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine All